Study of Sulphonylurea Synergy With DPP4 Inhibitors
NCT04192292
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Sulfonylurea
DRUG:
DPP4 Inhibitor
Sponsor
University of Dundee